Literature DB >> 29929749

Knockdown of TRIM66 inhibits malignant behavior and epithelial-mesenchymal transition in non-small cell lung cancer.

Huan-Yu Dai1, Yan Ma2, Zhao Da3, Xiao-Ming Hou4.   

Abstract

OBJECTIVE: The tripartite motif 66(TRIM66) is an important member of the TRIM protein superfamily, which can participate in the expression of multiple proteins, and is closely associated with the behaviors of non-small cell lung cancer (NSCLC). In this study, we aimed to explore the effect of TRIM66 in this process in vitro using NSCLC cell lines, and the role of TRIM66 in regulating epithelial-mesenchymal transition(EMT) in NSCLC.
METHODS: Western blotting was used to detect the TRIM66 protein expression levels in NSCLC cell lines and normal lung epithelial cells BEAS-2B. We silenced its expression in A549 cells by transient siRNA transfection to ascertain the function of TRIM66 in NSCLC cells. Western blotting was used to detect the expression of EMT-related proteins.
RESULTS: TRIM66 protein content was highest in NSCLC cell line A549, compared with BEAS-2B, it showed that the TRIM66-siRNA group lung cancer cell proliferation was significantly reduced after knockdown of TRIM66, and knockdown of TRIM66 also suppressed invasion, migration and clonogenic ability of A549 cells. Finally, we found that siRNA-mediated TRIM66 silencing suppressed EMT by downregulating expression of N-cadherin and vimentin and upregulating that of E-cadherin in NSCLC cells, which could effectively reduce the invasive, migratory, and proliferative capacities of lung cancer cells.
CONCLUSION: Silence TRIM66 expression suppressed NSCLC cell proliferation, invasion, and migration. The siRNA-mediated TRIM66 silencing could block the occurrence of EMT. TRIM66 could be a promising novel target for future NSCLC treatments.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  EMT; Malignant phenotype; NSCLC; TRIM66

Mesh:

Substances:

Year:  2018        PMID: 29929749     DOI: 10.1016/j.prp.2018.06.008

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

Review 1.  E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.

Authors:  Santina Venuto; Giuseppe Merla
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

2.  Bioinformatics analysis of prognostic value of TRIM13 gene in breast cancer.

Authors:  Wei-Xian Chen; Lin Cheng; Ling-Yun Xu; Qi Qian; Yu-Lan Zhu
Journal:  Biosci Rep       Date:  2019-03-22       Impact factor: 3.840

3.  miR-451a Inhibits the Growth and Invasion of Osteosarcoma via Targeting TRIM66.

Authors:  Xiao Ma; Dan Li; Yan Gao; Cheng Liu
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

4.  TRIM66 promotes malignant progression of prostate carcinoma through the JAK/STAT pathway.

Authors:  Hongwen Cao; Renjie Gao; Lei Chen; Yigeng Feng
Journal:  FEBS Open Bio       Date:  2020-03-03       Impact factor: 2.693

5.  The Association between TIF1 Family Members and Cancer Stemness in Solid Tumors.

Authors:  Patrycja Czerwinska; Nikola Agata Wlodarczyk; Anna Maria Jaworska; Andrzej Adam Mackiewicz
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

6.  TRIM66 Promotes Malignant Progression of Non-Small-Cell Lung Cancer Cells via Targeting MMP9.

Authors:  Yufen Xu; Qi Yang; Zhixian Fang; Xiaoli Tan; Ming Zhang; Wenyu Chen
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

7.  Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent manner.

Authors:  Weilin Wang; Jianhua Wang; Yingyi Li; Yongxu Zhao
Journal:  J Bone Oncol       Date:  2022-06-02       Impact factor: 4.491

Review 8.  TIF1 Proteins in Genome Stability and Cancer.

Authors:  Roisin M McAvera; Lisa J Crawford
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

9.  TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.

Authors:  Ming Lou; Zhaojia Gao; Tao Zhu; Xiaoliang Mao; Yeming Wang; Kai Yuan; Jichun Tong
Journal:  Oncol Lett       Date:  2019-12-10       Impact factor: 2.967

10.  TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling.

Authors:  Yuequn Song; Lifang Meng; Jian Yu; Zhi Cao; Jizhou Sun; Hongyu Zhao
Journal:  Cancer Manag Res       Date:  2021-06-30       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.